Hauv kev sib tw hnyav Nootropics thiab E-kev ua si ntxiv kev ua lag luam, L- -Glycerophosphocholine (Alpha-GPC) yog universally lees paub tias yog apex choline pub. Nws hla cov ntshav sai sai- lub hlwb teeb meem los ua ke acetylcholine, xa cov kev tsom xam tam sim thiab kev txawj ntse. Txawm li cas los xij, ib lub Koom Haum Ua Lag Luam Daim Ntawv Cog Lus (CMO) uas tau ua haujlwm nrog Alpha ntshiab -GPC paub txog kev lag luam npau suav phem uas nws tshwm sim hauv pem teb hauv tsev.

NtawmXi'an Tihealth (Xi'an Tihealth Biotechnology Co., Ltd.), peb tshawb xyuas tsis ua tiav nootropic formulations thoob ntiaj teb. Qhov feem ntau ntawm qhov tsis ua haujlwm tsis yog qhov ntau npaum li cas; nws yog qhov kev puas tsuaj hygroscopicity ntawm cov khoom siv raw. Ntshiab 99% Alpha-GPC yuav cia li tig mus rau hauv cov av nplaum nplaum thaum feeb ntawm qhov raug rau cov av noo nyob ib puag ncig. Cov lus qhia no qhia txog kev tsim cov biophysics ntawm choline tus me nyuam, kev lag luam kev puas tsuaj ntawm deliquescence nyob rau hauv capsule tshuab, thiab vim li cas peb 50% Micro-encapsulated hmoov yog tib API siv tau rau khoom noj khoom haus - koob tshuaj.

Formulators feem ntau sim txiav cov nqi los ntawm kev hloov Alpha-GPC nrog Choline Bitartrate lossis Choline Chloride. Qhov no yog kev kho mob yuam kev. Standard choline ntsev tsis muaj lipophilic thauj mechanism yuav tsum tau ua txhaum cov ntshav-Brain Barrier (BBB). Alpha-GPC yog qhov txawv vim tias choline molecule raug khi rau glycerophosphate qaum.

Cov qauv no ua haujlwm rau ob lub hom phiaj: choline ua tus thawj coj ncaj qha rau cov neurotransmitter Acetylcholine (txhim kho lub cim xeeb sib koom ua ke thiab rov ua kom nrawm), thaum lub glycerophosphate ua qhov precursor rau neuronal membrane phospholipids. Rau siab -stakes applications-txawm nws yog tus thawj tswj lub zog mis los yog ib tug neuro- tiv thaiv rau kev txawj ntse poob -Alpha-GPC muab ib tug neurochemical payload uas pheej yig dua ntsev tsuas yog lub cev tsis tuaj yeem xa.

Txawm hais tias nws cov khoom noj muaj txiaj ntsig zoo tshaj plaws, cov ntshiab Alpha-GPC (99%) yog cov dej tsis zoo. Nws nthuav tawm ib qho phenomenon hu uadeliquescence-nws nqus dej noo ntau heev los ntawm huab cua uas nws yaj hauv nws cov dej nqus. Yog tias koj pab neeg yuav khoom yuav 99% crystalline hmoov rau qhuav -capsule khiav, koj tab tom taug kev mus rau kev puas tsuaj ntau lawm.

Lub sijhawm cov khoom siv raw tawm hauv lub tshuab nqus tsev- kaw lub nruas thiab ntaus lub hopper ntawm lub tshuab ua teb capsule filling tshuab, nws pib rub cov av noo. Hauv feeb, cov hmoov yuav nplaum. Nws yuav ua raws li cov pins tamping, clog lub dosing disks, thiab ua rau muaj kev hloov pauv loj heev hauv cov tshuaj ntsiav zaum kawg. Cov neeg ua haujlwm yuav raug yuam kom kaw txoj kab txhua 20 feeb kom chisel cov gummy residue tawm ntawm cov cuab yeej. Koj tsis tuaj yeem "dehumidify" koj txoj kev tawm ntawm lub cev zoo li no.

Txhawm rau ua lag luam Alpha-GPC hauv cov qauv tshuaj, cov qauv tsim yuav tsum tau txaisMicro-encapsulated Alpha-GPC 50%. Ntawm Xi'an Tihealth, peb siv cov kua dej siab tshaj -txheej txheej txheej tshuab los ua kom muaj kev ua haujlwm pub dawb - ntws, ya raws-shielded API.

• Excipient Shield:Peb txheej cov active Alpha-GPC molecule nyob rau hauv ib tug tiv thaiv matrix (feem ntau yog siv Dibasic Calcium Phosphate los yog silicas tshwj xeeb). Qhov kev tiv thaiv lub cev no thaiv ambient noo noo cuam tshuam, xauv lub active payload nyob rau hauv ib tug ruaj khov, qhuav lub xeev.
• Flowability thiab Compressibility:Cov qib 50% granular coj tus cwj pwm tsis zoo nyob rau hauv siab -kev tsim khoom ceev. It possesses an optimized bulk density and exceptional flow characteristics, completely eliminating punch-sticking and ensuring uniform dose distribution across thousands of capsules.
• Hygroscopic Neutralization:Los ntawm kev txi 50% ntawm qhov hnyav hnyav rau kev tiv thaiv txheej, peb ua tiav 100% kev ntseeg siab ua haujlwm. Formulators tsuas yog muab ob npaug rau qhov kev nkag siab qhov hnyav hauv tus qauv qauv kom ua tiav qhov xav tau tshuaj kho mob yam tsis muaj kev pheej hmoo rau lub Hoobkas kaw.

Txhawm rau xyuas kom koj cov tshuaj nootropic muaj sia nyob kev tsim khoom thiab kev thauj mus los yam tsis muaj kev sib tsoo rau hauv gel, ua raws li cov lus qhia ntawm lub cev:

Technical Parameters	Xi'an Tihealth Specification (API Granular Qib)	Test Method & R & D Advantage
Molecule Nomenclature	L- -Glycerophosphocholine (Alpha-GPC 50%)	--
Assay (Cov ntsiab lus nquag)	Ntau dua lossis sib npaug li 50.0%	HPLC (Tshuaj xyuas qhov tseeb choline pub dawb payload).
Qhov tshwm sim	Dawb rau Tawm-Dawb Dawb-Flowing Granular Powder	Visual (Indicates vam meej micro-encapsulation).
Loss ntawm ziab (Moisture)	Tsawg dua lossis sib npaug li 2.0%	Gravimetric (Kev txwv tseem ceeb los tiv thaiv cov tshuaj ntsiav muag).
Particle Loj	100% dhau 80 mesh	Sieve Analysis (ua kom siab -ceev flowability).
Heavy Metals (Pb, As)	Tsawg dua lossis sib npaug li 1.0 ppm	ICP-MS (Yuav tsum tau rau neuro-kev nyab xeeb tiv thaiv).
Microbial txwv (TPC)	Tsawg dua lossis sib npaug li 1000 cfu / g	USP<61>(Txhim kho qhov chaw kho mob-qib purity).

• Phau ntawv Journal ntawm International Society of Sports Nutrition: Cov teebmeem ntawm alpha-glycerylphosphorylcholine, caffeine lossis placebo ntawm cov cim ntawm lub siab, kev paub txog kev ua haujlwm, lub zog, ceev, thiab agility.(Ua pov thawj E- kis las thiab kis las ncaws pob).
  URL:https://jissn.biomedcentral.com/
• Clinical Therapeutics: Kev paub txog kev txhim kho me me mus rau nruab nrab Alzheimer's dementia tom qab kho nrog acetylcholine precursor choline alfoscerate.(Clinical validation of BBB penetration).
  URL:https://pubmed.ncbi.nlm.nih.gov/12637119/
• Pharmaceutical Development thiab Technology: Cov tswv yim rau kev tsim cov khoom xyaw tshuaj hygroscopic heev.(Kev lees paub lub micro-encapsulation mandate).
  URL:https://www.tandfonline.com/loi/iphd20

Q: Kuv puas tuaj yeem siv 50% Micro-encapsulated Alpha-GPC hauv kua RTD (Npaj-Rau- Haus) txhaj tshuaj lub zog?

Tsis yog. Qib 50% yog coated hnyav nrog cov khoom siv tsis zoo (xws li calcium phosphates) tsim tshwj xeeb los thaiv cov dej noo. Yog tias koj muab tso rau hauv dej, nws yuav tsis yaj; nws yuav tsim ib tug pos huab suspension thiab precipitate. Rau cov dej ua haujlwm ua kua, koj yuav tsum siv covAlpha{0}}GPC 99% Kua/Syruplos yog lis 99% hmoov nyob rau hauv nruj heev huab cua- tswj ib puag ncig.

Q: Puas yog cov tshuaj ntxiv hauv 50% hmoov cuam tshuam nrog kev nqus ntawm choline?

Tsis yog. Lub micro-encapsulation matrix yog tsim los ua kom tawg sai sai hauv cov kua qaub ib puag ncig ntawm lub plab, tso Alpha-GPC payload tam sim rau kev nqus nyob rau hauv GI sab sauv. Lub pharmacokinetic profile tseem zoo ib yam rau cov hmoov ntshiab.

Q: Peb cov tshuaj ntsiav tau ua mos thiab deformed hauv lub raj mis tom qab ob lub hlis. Vim li cas?

Qhov no yog ib tug classic tsos mob ntawmhygroscopic migration. Yog tias koj siv cov ntshiab 99% Alpha-GPC, lossis qis- zoo 50% sib xyaw, cov khoom siv raw yog rub cov dej noo tawm ntawm cov huab cua ib puag ncig thiab tawm ntawm gelatin / HPMC capsule plhaub nws tus kheej, ua rau lub plhaub tawg. Hloov mus rau Xi'an Tihealth's precisely coated 50% granular API kiag li nres no ya raws hloov.

Kev Txiav Txim Siab: Txhim Kho Koj Cov Choline

Kev ua lag luam nootropics yog unforgiving rau amateur formulators. Tsis txhob kaw koj cov kab encapsulation kom chisel tawm melted choline. Tsis txhob cuam tshuam nrog deformed capsules thiab hnyav inconsistencies.

Tshawb xyuas koj qhov flowability. Xav tau noo noo-shielded micro-encapsulation. Tsom ntsoov rau kev xa cov payload ntseeg tau.Npaj kom ruaj khov koj lub hlwb -cov qauv kev noj qab haus huv? Hu rau Xi'an Tihealth pab pawg kws tshaj lij hnub no kom ruaj ntseg tshuaj -qib Alpha-GPC 50% Granular API.